Veeva Align customers cut time to create territory alignments by 75%
PLEASANTON, CA — 29 Nov. 2017 — Veeva Systems (NYSE: VEEV) announced today that four of the top 20 pharmaceutical companies have adopted Veeva Align across various regions to perform fast, accurate territory alignments. Veeva also launched new target planning capabilities in Veeva Align to simplify the creation of multichannel cycle plans and deliver them in Veeva CRM, helping sales operations more efficiently drive execution across the right mix of channels.
Companies such as Astellas use Veeva Align to significantly reduce time to create alignments. “Operating with greater agility is a key principle for Astellas,” said Ian Knowlton, senior director, head of CRM, Astellas, a leading global pharmaceutical company. “Veeva Align allows us to make major changes to sales force territories faster and more precisely. Alignments that used to take five days now take as little as a few minutes.”
Organizations typically rely on spreadsheets, multiple systems, or third-party vendors to support territory alignments, which are often a time-consuming, costly administrative burden. As a result, sales operations struggles to keep pace with customer changes and assign the right field resources to the right physicians.
Veeva Align helps companies deliver the right alignments faster. On average, Veeva Align customers decreased time to create territory alignments by 75% and saw a tenfold reduction in process steps. Integration with Veeva CRM eliminates handoffs and enables seamless field collaboration. Field reps can provide feedback right in Veeva CRM, allowing sales operations to improve accuracy and more quickly optimize territory alignments.
To help life sciences companies transform their customer engagement across multiple channels, Veeva announced new target planning capabilities in Veeva Align to simplify multichannel cycle planning. Sales operations can set activity goals using criteria such as customer segmentation and sales history, prioritize customer targets, generate multichannel cycle plans, and deliver them directly into Veeva CRM for the field to execute. This makes planning easier and more efficient as companies expand their customer engagement across various channels.
“Veeva Align gives sales operations full control of their multichannel activity planning,” said Emily Kranz, senior director of strategy for Veeva Align. “For the first time, companies can align and target their customers in a single application to close the gap between their sales strategy and execution and more quickly respond to the needs of the business.”
In other news today, Veeva announced availability of Veeva CRM Engage Webinar, the first purpose-built application to manage compliant virtual events in the life sciences industry, and Veeva Vault PromoMats Brand Portal, a new digital asset management capability that makes it simple for brand managers to create portals and organize and showcase content within Veeva Vault PromoMats. Read the Veeva CRM Engage Webinar news and the Vault PromoMats Brand Portal news to learn more.
For more on Veeva Align, visit: veeva.com/Align
Stay updated on the latest Veeva news on LinkedIn: www.linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: www.twitter.com/veevasystems
Like Veeva on Facebook: www.facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 550 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit www.veeva.com.
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended July 31, 2017. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.